Sphingosine-1-Phosphate and Its Signal Modulators Alleviate Psoriasis-Like Dermatitis: Preclinical and Clinical Evidence and Possible Mechanisms

Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis

(2021) Juan S. Lasa et al.   DRUG SAFETY

Fingolimod ameliorates imiquimod-induced psoriasiform dermatitis by sequestrating interleukin-17-producing γδ T cells in secondary lymph nodes

(2021) Iori Okura et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Adverse Events Associated With Anti-IL-23 Agents: Clinical Evidence and Possible Mechanisms

(2021) Yi Ru et al.   Frontiers in Immunology

Finding a Way Out: S1P Signaling and Immune Cell Migration

(2020) Audrey A.L. Baeyens et al.   Annual Review of Immunology

Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

(2020) Julita Anna Krahel et al.   Journal of Clinical Medicine

Inhibition of sphingosine 1phosphate lyase activates human keratinocyte differentiation and attenuates psoriasis in mice

(2019) Suwon Jeon et al.   JOURNAL OF LIPID RESEARCH

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

(2019) Andreane Cartier et al.   SCIENCE

A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models

(2019) Jing Jin et al.   Acta Pharmaceutica Sinica B

Validating a Selective S1P1 Receptor Modulator Syl930 for Psoriasis Treatment

(2018) Ming Ji et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Psoriasis and the metabolic syndrome

(2018) Paolo Gisondi et al.   CLINICS IN DERMATOLOGY

Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment

(2017) Stephen Hu et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Estimating data from figures with a Web-based program: Considerations for a systematic review

(2017) Brittany U. Burda et al.   Research Synthesis Methods

Increase in circulating sphingosine-1-phosphate and decrease in ceramide levels in psoriatic patients

(2016) Hanna Myśliwiec et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Association of Serum Uric Acid Levels in Psoriasis

(2016) Xin Li et al.   MEDICINE

Psoriasis

(2015) Wolf-Henning Boehncke et al.   LANCET

Update on psoriasis immunopathogenesis and targeted immunotherapy

(2015) Satveer K. Mahil et al.   Seminars in Immunopathology

Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis

(2015) Xin Li et al.   PLoS One

SYRCLE’s risk of bias tool for animal studies

(2014) Carlijn R Hooijmans et al.   BMC Medical Research Methodology

Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial

(2014) Andrea Vaclavkova et al.   LANCET

Sphingolipid metabolites in inflammatory disease

(2014) Michael Maceyka et al.   NATURE

Sphingosine-1-phosphate exhibits anti-proliferative and anti-inflammatory effects in mouse models of psoriasis

(2013) Katrin Schaper et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

(2012) Rosa Parisi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Sphingosine 1-phosphate receptor 1 and 3 are upregulated in multiple sclerosis lesions

(2010) Ruben Van Doorn et al.   GLIA

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis

(2010) Volker Brinkmann et al.   NATURE REVIEWS DRUG DISCOVERY

Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis

(2010) Jeffrey A. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Sphingosine 1-Phosphate Restrains Insulin-Mediated Keratinocyte Proliferation via Inhibition of Akt through the S1P2 Receptor Subtype

(2008) Melanie Schüppel et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY